New book by Larry Connors Click here Improve your trading - See how
The Newest and Revolutionary Technology for Increasing Investor Visability.
REAL Awareness for REAL Companies.
Click below for a full demonstration.
http://newmediaadvisors.info/newmedia.swf
Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com
Nov 13, 2008 -- Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company is focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that a letter to shareholders from CEO Matthew Schissler has been posted on the Company's website. The letter explains some of the positive scientific and economic implications of the potential enhanced stem cell research initiatives proposed by the new Obama Administration.
On Sunday, November 9, 2008, John Podesta, who is leading President Elect Barack Obama's transition team, told Fox News (http://www.foxnews.com/story/0,2933,449164,00.html):
"We're looking at -- again, in virtually every agency to see where we can move forward, whether that's on energy transformation, on improving health care, on stem cell research.
There's a lot that the president can do using his executive authority without waiting for congressional action, and I think we'll see the president do that ..."
Mr. Schissler commented, "Because of this interview, there seems to be a rejuvenated and heightened awareness to stem cells and the philosophy change that is anticipated from our President Elect. It is my hope that, through a series of communicative letters to shareholders and families alike, that CBAI can provide valuable information from both a macroeconomic perspective, as well as a direct relation to the individual."
"I am often asked the question: 'What does this mean for Cord Blood America?'" Mr. Schissler said. "Families ask us: 'What does this mean for my family, should I store stem cells, what are the differences between embryonic and adult stem cells, and what does the research mean to our medical community and our economy?'"
"We believe the letter that was posted today and which can be accessed at http://www.cordblood-america.com will help answer some of these questions," Cord Blood America's CEO said. "In summary, we believe that an infusion of capital into stem cell research and development will lead to more therapies being commercialized, a higher percentage of families benefiting from these therapies and, subsequently, a higher percentage of families choosing to store stem cells. We believe this is a significant positive for both stem cell companies and our shareholders."
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.
Nov 13, 2008 -- Envit Capital Group, Inc., (PINKSHEETS: ECGP | Quote | Chart | News | PowerRating) announced today exploring the opportunity to do an additional reverse merger to excel onto the Over The Counter Bulletin Board (OTCBB). This action will take place without any reverse split to current shareholders. Envit Capital will be releasing its financial data shortly, at which time would allow the company to complete a reverse merger onto the OTCBB.
About The Envit Capital Group, Inc.
The Envit Capital Group, Inc. is a development stage boutique investment banking, securities and investment management firm that will provide a range of services to a client base that will include business, institutions, and high-net-worth individuals. Its objective is to be active in all three of the following segments: Investment Banking, Trading and Principal Investments, and Asset Management and Securities Services.
Nov 13, 2008 -- International Stem Cell Corporation (OTCBB: ISCO). In the emerging field of regenerative medicine one topic that has earned its fair share of notoriety is the issue of embryonic stem cell research. Stem cells are characterized by the ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. Since stem cells can be grown and transformed into specialized cells with characteristics consistent with various tissue such as muscles or nerves, their use in medical therapies has been prized. The goal of any stem cell therapy is to repair damaged tissue that can't heal itself, which might be accomplished by transplanting stem cells into damaged areas and directing them to grow new, healthy tissue.
However, a widespread controversy exists over human embryonic stem cell research emanating from certain techniques used in their creation and usage. The practice is controversial because, using current methods, starting a stem cell line requires the destruction of a human embryo. The pro-life movement argues that a human embryo is a human life and is therefore entitled to protection.
Fortunately, there is a silver lining. "Through a procedure known as parthenogenesis, an unfertilized human egg can be chemically induced to form a tiny cluster of cells from which a stem cell line can be created, thereby solving the ethical problem of using fertilized human embryos," explains Mr. Kenneth C. Aldrich, CEO of International Stem Cell Corporation, the only company to generate functional pluripotent stem cells, (that is, stem cells that have the ability to turn into any type of cell or tissue), through parthenogenesis.
Recently, the company reported that by using its proprietary technique, cells from a single donor could be matched to general genetic patterns of hundreds of millions of patients. Since a single line of these cells may eliminate immune rejection issues in large segments of the population, parthenogenetic stem cells will be enormously valuable as a treatment of choice for diseases including diabetes, heart disease, and certain types of cancer. "Practically speaking," says Mr. Aldrich, "if stem cells could be made to grow into tissues and organs, waiting lists for transplant recipients would become a thing of the past."
Nov 12, 2008 -- Universal Detection Technology (OTCBB: UNDT/Frankfurt: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, today issued an analysis of the rise of "suspicious powder mailings" as well as reports of a fatality caused by inhalation anthrax in the United Kingdom.
In the last month more than 30 letters containing a suspicious powder were mailed to Chase bank branches and federal banking regulators' offices in nine cities. According to a law enforcement official, the letters were mailed to Chase bank branches in or near Atlanta, Chicago, Columbus, Ohio, Dallas, Denver, Newark, N.J., New York City, Oklahoma City and Washington.
The FBI has arrested a 66-year-old US national suspected of mailing more than 120 packages marked "anthrax" to media outlets. The white powder was found to be harmless, said the FBI, but recipients of the packages were told to not touch the substance and report the instance as quickly as possible. The packages were sent along with a compact disc titled "Anthrax: Shock & Awe Terror," and decorated with the image of former secretary of state Colin Powell.
The FBI also released a report that it had investigated over 900 threats made with envelopes containing white powder probably meant to look like anthrax. "Interesting enough, over the past two-years, the FBI has responded to over 900 of these threat letters," said FBI spokesman Rich Kolko. "Even sending a hoax letter is a serious crime," he added.
Earlier this month a man in London died of anthrax after inhaling anthrax spores while handling imported animal skins. The death sparked a health alert in London and the Health Protection Agency is examining the home and workshop of the victim. This is the second incident in the last 2 years where a drum maker in the U.K. has died after exposure to animal hide tainted with anthrax.
UNDT's anthrax detection equipment has been extensively used by first responders and private industry throughout the country. The equipment has been evaluated by the U.S. DOD as well as the United Kingdom military. The equipment can notify a first responder of the presence of anthrax in as little as three minutes. UNDT's BSM-2000 system is an autonomous airborne detector of bacterial spores. The system samples the ambient air and can notify a first responder of elevated levels of bacterial spores which is a typical signature of an airborne anthrax attack.
"The rise in the incidence of suspicious powder scares and mailings usually correlates with a rise in the levels of public insecurity. This may be caused either by international or domestic terrorist incidents or more recently by the financial crisis," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer. "Our nation's first responders need to be ever vigilant and treat each incident as an actual attack and prosecute the perpetrators of these hoaxes," he added.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products.
Nov 12, 2008 -- VIASPACE Inc. (OTCBB: VSPC), announced today that that its VIASPACE Energy business unit has shipped a HS-1000 VIASENSOR, a state of the art, laser-based humidity detection instrument, to a new customer in Taiwan. The order was placed by VIASPACE Taiwan partner Hephas Energy on behalf of a major Taiwanese government research laboratory for hydrogen fuel cell development applications.
"We are happy to have another VIASENSOR instrument placed in world-class laboratory," reported VIASPACE CEO Dr. Carl Kukkonen. "We are gaining a global presence and worldwide reputation for leadership in humidity measurements. The laser-based VIASENSOR is much faster and easier to use with lower maintenance than the conventional chilled mirror instrument. A leading Japanese automotive manufacturer extensively tested the VIASENSOR against a chilled mirror and a capacitive device in static and dynamic humidity streams. The VIASENSOR won and the automotive manufacturer has purchased three systems. Our sales force regularly demonstrates the VIASENSOR advantages to potential customers."
The VIASENSOR makes real-time measurements of humidity levels in industrial and automotive gas streams for environmental monitoring and process control. Precise humidity levels are crucial in many industrial and commercial applications including steelmaking, fuel cells, baking and precision automotive exhaust measurements.
The performance of hydrogen fuel cells using a Polymer Electrolyte Membrane (PEM) depends on the moisture level of the membrane. The membrane only conducts protons when it is hydrated or moist. The moisture is provided by water vapor in the incoming air or hydrogen stream. The VIASENSOR HS-1000 provides real-time measurements of the amount of water vapor in these gas streams. It is the only humidity sensor that provides in-situ, continuous and fast-responding dew point measurement.
About VIASPACE
Originally founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA's Jet Propulsion Laboratory. In addition, VIASPACE has recently acquired a profitable company, which also has a license to grow a fast-growing grass for animal feed and as a feedstock for biofuels.
About Standoutstocks.com
Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx
CONTACT: Standoutstocks.com e-mail: info@standoutstocks.com WWW: http://www.standoutstocks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
